PAIN
Volume 139, Issue 2 , Pages 479-480, 15 October 2008

Role of placebo factors in clinical trials with special focus on enrichment designs

  • Roland Staud

      Affiliations

    • Corresponding Author InformationTel.: +1 352 273 5346; fax: +1 352 392 8483.

Received 10 July 2008; accepted 28 July 2008. published online 15 September 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0304-3959(08)00424-7

doi:10.1016/j.pain.2008.07.027

Refers to article:

  • Response to: Long-term trials of pregabalin and duloxetine for fibromyalgia symptoms: How study designs can affect placebo factors , 15 September 2008

    R.A. Moore, S. Derry, H.J. McQuay
    PAIN 15 October 2008 (Vol. 139, Issue 2, Pages 477-479)

PAIN
Volume 139, Issue 2 , Pages 479-480, 15 October 2008

Article Tools